Adcentrx Therapeutics Funding: $88M Raised, Series A (2024)
Adcentrx Therapeutics is based in San Diego, California. It has raised $88M in total funding. Latest round: Series A.
Adcentrx Therapeutics funding overview
Adcentrx Therapeutics is based in San Diego, California. Adcentrx Therapeutics has raised $88M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Adcentrx Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include CBC Group, Eight Roads Ventures, Zoo Capital, Boyu Capital. 4 distinct backers are named across the disclosed rounds.
Adcentrx Therapeutics at a glance
Total raised
$88M
Latest round
Series A
Latest round date
January 2024
Headquarters
San Diego, California
Notable investors
CBC Group, Eight Roads Ventures, Zoo Capital, Boyu Capital
Frequently asked about Adcentrx Therapeutics funding
How much has Adcentrx Therapeutics raised?
Adcentrx Therapeutics has raised $88M in total disclosed funding across the rounds on record.
Who has invested in Adcentrx Therapeutics?
CBC Group, Eight Roads Ventures, Zoo Capital, Boyu Capital are named among the investors backing Adcentrx Therapeutics.
What was the latest Adcentrx Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Adcentrx Therapeutics based?
Adcentrx Therapeutics is based in San Diego, California.
When did Adcentrx Therapeutics last raise?
The last disclosed Adcentrx Therapeutics round closed in January 2024 at Series A.
Adcentrx Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
